UK Approves Gene-Edited Safer Wheat in Landmark Precision Breeding Milestone

A new variety of gene-edited wheat has officially received "precision bred" status under the UK's Genetic Technology Act, marking a major milestone for food safety and agricultural innovation. Developed by researchers using CRISPR genome editing, this specialized crop targets a significant health challenge by dramatically reducing the presence of free asparagine, a naturally occurring amino acid that converts into the toxic, potentially cancer-causing contaminant acrylamide when wheat is baked, toasted, or fried.

The breakthrough comes as European regulators prepare to tighten maximum limits on dietary acrylamide, putting immense pressure on the global food supply chain to mitigate the contaminant at its source. During two years of rigorous field trials, scientists successfully knocked down free asparagine levels by 59 percent by targeting the crop's asparagine synthetase-2 (TaASN2) gene. Crucially, this genetic modification achieved the safety improvement without compromising overall grain yields, ensuring the wheat remains commercially viable for farmers.

Backed by the Department for Environment, Food and Rural Affairs (Defra) as part of the £2.2 million farmer-led PROBITY project, the approval clears the path for the crop to leave the lab. The wheat will now move forward into real-world testing, where it will be grown on select commercial farms and processed in manufacturing plants. Proponents of the technology emphasize that the successful ruling demonstrates that the UK's new regulatory framework is functioning exactly as intended, allowing safe, beneficial, and precisely engineered crop traits to move efficiently from scientific discovery onto consumers' plates.

For more details, read the news article in Rothamsted Research.